Anbio Biotechnology (NNNN) Equity Average (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Anbio Biotechnology has reported Equity Average over the past 2 years, most recently at $23.7 million for Q4 2025.

• Quarterly results put Equity Average at $23.7 million for Q4 2025, up 47.91% from a year ago — trailing twelve months through Dec 2025 was $23.7 million (up 47.91% YoY), and the annual figure for FY2025 was $23.7 million, up 47.91%.
• Equity Average for Q4 2025 was $23.7 million at Anbio Biotechnology, up from $16.0 million in the prior quarter.
• Over the last five years, Equity Average for NNNN hit a ceiling of $23.7 million in Q4 2025 and a floor of $16.0 million in Q4 2024.

Peer Comparison